Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Aplisol
- Development stage
- Unknown
- Lead developer
- Par Pharmaceutical
- Modality
- Recombinant Proteins and Enzymes
- Administration
- Intradermal
01
Overview
Aplisol is a sterile aqueous solution of Tuberculin Purified Protein Derivative (PPD) used for the Mantoux skin test to detect infection with *Mycobacterium tuberculosis*. Developed by JHP Pharmaceuticals (now part of Par Pharmaceutical), it contains antigens derived from *M. tuberculosis* cultures. Upon intradermal administration, it elicits a delayed-type hypersensitivity (DTH) reaction in individuals with cellular immunity to the pathogen, typically manifesting as induration at the injection site within 48 to 72 hours. Clinical studies by JHP Pharmaceuticals have focused on establishing the equivalence of new production batches of Aplisol against the PPD-S2 reference standard to ensure consistent potency and specificity in diagnostic settings.
- Brand names
- Aplisol
- Other names
- Tuberculin Purified Protein DerivativePPDTuberculin PPD
Beyond the preview
Go deeper on Aplisol.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Aplisol.